These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12370078)

  • 1. Selective agonists and antagonists for kainate receptors.
    Conti P; De Amici M; De Micheli C
    Mini Rev Med Chem; 2002 Apr; 2(2):177-84. PubMed ID: 12370078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kainate receptor agonists, antagonists and allosteric modulators.
    Bleakman D; Gates MR; Ogden AM; Mackowiak M
    Curr Pharm Des; 2002; 8(10):873-85. PubMed ID: 11945137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropharmacology of AMPA and kainate receptors.
    Bleakman D; Lodge D
    Neuropharmacology; 1998; 37(10-11):1187-204. PubMed ID: 9849657
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological characterization of glutamatergic agonists and antagonists at recombinant human homomeric and heteromeric kainate receptors in vitro.
    Alt A; Weiss B; Ogden AM; Knauss JL; Oler J; Ho K; Large TH; Bleakman D
    Neuropharmacology; 2004 May; 46(6):793-806. PubMed ID: 15033339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excitatory amino acid agonists and antagonists: pharmacology and therapeutic applications.
    Trist DG
    Pharm Acta Helv; 2000 Mar; 74(2-3):221-9. PubMed ID: 10812962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative antagonism of kainate-activated kainate and AMPA receptors in hippocampal neurons.
    Paternain AV; Vicente A; Nielsen EO; Lerma J
    Eur J Neurosci; 1996 Oct; 8(10):2129-36. PubMed ID: 8921304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy.
    Löscher W; Lehmann H; Behl B; Seemann D; Teschendorf HJ; Hofmann HP; Lubisch W; Höger T; Lemaire HG; Gross G
    Eur J Neurosci; 1999 Jan; 11(1):250-62. PubMed ID: 9987029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligands for glutamate receptors: design and therapeutic prospects.
    Bräuner-Osborne H; Egebjerg J; Nielsen EO; Madsen U; Krogsgaard-Larsen P
    J Med Chem; 2000 Jul; 43(14):2609-45. PubMed ID: 10893301
    [No Abstract]   [Full Text] [Related]  

  • 9. Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia.
    O'Neill MJ; Bond A; Ornstein PL; Ward MA; Hicks CA; Hoo K; Bleakman D; Lodge D
    Neuropharmacology; 1998; 37(10-11):1211-22. PubMed ID: 9849659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission.
    Clarke VR; Ballyk BA; Hoo KH; Mandelzys A; Pellizzari A; Bath CP; Thomas J; Sharpe EF; Davies CH; Ornstein PL; Schoepp DD; Kamboj RK; Collingridge GL; Lodge D; Bleakman D
    Nature; 1997 Oct; 389(6651):599-603. PubMed ID: 9335499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NS-257, a novel competitive AMPA receptor antagonist, interacts with kainate and NMDA receptors.
    Nijholt I; Blank T; Grafelmann B; Cepok S; Kügler H; Spiess J
    Brain Res; 1999 Mar; 821(2):374-82. PubMed ID: 10064824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained ethanol inhibition of native AMPA receptors on medial septum/diagonal band (MS/DB) neurons.
    Frye GD; Fincher A
    Br J Pharmacol; 2000 Jan; 129(1):87-94. PubMed ID: 10694206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of willardiine and 6-azawillardiine analogs: pharmacological characterization on cloned homomeric human AMPA and kainate receptor subtypes.
    Jane DE; Hoo K; Kamboj R; Deverill M; Bleakman D; Mandelzys A
    J Med Chem; 1997 Oct; 40(22):3645-50. PubMed ID: 9357531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive and negative modulation by AMPA- and kainate-receptors of striatal kainate injection-induced neuronal loss in rat forebrain.
    Zhu X; Jin S; Ng YK; Lee WL; Wong PT
    Brain Res; 2001 Dec; 922(2):293-8. PubMed ID: 11743962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMPA/kainate receptor activation in murine oligodendrocyte precursor cells leads to activation of a cation conductance, calcium influx and blockade of delayed rectifying K+ channels.
    Borges K; Ohlemeyer C; Trotter J; Kettenmann H
    Neuroscience; 1994 Nov; 63(1):135-49. PubMed ID: 7898644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dicarboxyphenylglycines antagonize AMPA- but not kainate-induced depolarizations in neonatal rat motoneurones.
    Thomas NK; Clayton P; Jane DE
    Eur J Pharmacol; 1997 Nov; 338(2):111-6. PubMed ID: 9455991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of MAPK/ERK phosphorylation via ionotropic glutamate receptors in cultured rat striatal neurons.
    Mao L; Tang Q; Samdani S; Liu Z; Wang JQ
    Eur J Neurosci; 2004 Mar; 19(5):1207-16. PubMed ID: 15016079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overactivation of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate and N-methyl-D-aspartate but not kainate receptors inhibits phosphatidylcholine synthesis before excitotoxic neuronal death.
    Gasull T; DeGregorio-Rocasolano N; Trullas R
    J Neurochem; 2001 Apr; 77(1):13-22. PubMed ID: 11279257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection by metabotropic glutamate receptor agonists on kainate-induced degeneration of motor neurons in spinal cord slices from adult rat.
    Pizzi M; Benarese M; Boroni F; Goffi F; Valerio A; Spano PF
    Neuropharmacology; 2000 Mar; 39(5):903-10. PubMed ID: 10699456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ionotropic and metabotropic glutamate receptor structure and pharmacology.
    Kew JN; Kemp JA
    Psychopharmacology (Berl); 2005 Apr; 179(1):4-29. PubMed ID: 15731895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.